Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,428 GBX | -0.66% |
|
-1.37% | +17.25% |
04:09pm | Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco... | ![]() |
01:21pm | AstraZeneca Says FDA Approves Imfinzi to Treat Endometrial Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.25% | 25TCr | |
+51.39% | 79TCr | |
+40.45% | 63TCr | |
+17.46% | 33TCr | |
+9.13% | 30TCr | |
+0.41% | 22TCr | |
+10.22% | 22TCr | |
+4.54% | 16TCr | |
-5.78% | 16TCr | |
-2.33% | 12TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Lung Cancer Drug Shows Clinically Meaningful Improvement in Overall Survival